CAMBRIDGE, Mass.--(BUSINESS WIRE)--June 8, 2006--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX - News), a developer of innovative pharmaceuticals for magnetic resonance imaging (MRI), and Predix Pharmaceuticals, which has signed a definitive merger agreement with EPIX, announced today that the companies’ presentation at the Pacific Growth Equities Life Sciences Growth Conference 2006 will be webcast live.
